Hiroyuki Sakurai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Sakurai has a total of 165 co-authors. Here are the top co-authors by number of shared publications:
- Shugo Mizuno
Department of Hepatobiliary Pancreatic and Transplant Surgery Mie University Graduate School of Medicine Tsu Japan
28 shared publications - Shuji Isaji
Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan
26 shared publications Masashi Kishiwada
Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Hepatobiliary Pancreatic and Transplant Surgery, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
23 shared publications- Naohisa Kuriyama
Department of Hepatobiliary Pancreatic and Transplant Surgery Mie University Graduate School of Medicine Tsu Japan
22 shared publications - Masanobu Usui
Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Mie, Japan
21 shared publications Yoshinori Azumi
Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Hepatobiliary Pancreatic and Transplant Surgery, Mie University School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan
19 shared publications
Latest Publications
- 13 July 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (12) , 9054-9063
Resection type is a predictor of postoperative complications in laparoscopic partial liver resection
Background Partial laparoscopic liver resection (LLR) is a procedure that can have varying levels of surgical difficulty depending on the tumor status and procedure. Therefore, we aimed to evaluate the surgical outcomes of partial LLR using a new resection classification system. Methods From January 2009 to May 2021, 156 patients underwent LLR; of them, 87 patients who underwent pure partial LLR were included in this study. They were classified according to the IWATE criteria as the low (n = 56) and intermediate (n = 31) difficulty groups and reclassified according to the resection type as the edge (ER, n = 45), bowl-shaped (BSR, n = 27), and dome-shaped resection (DSR, n = 15) groups. The following surgical outcomes were comparatively analyzed among the groups: intraoperative blood loss, the operation time, and complication rates. Preoperative risk factors for intraoperative blood transfusion and complications were evaluated. Results In the IWATE criteria-based analysis, the intermediate-difficulty group had significantly higher intraoperative blood loss (p = 0.005), operation time (p = 0.005), and Clavien–Dindo (CD) grade-based complication rates (CD grade 2 or higher, p = 0.03) than the low-difficulty group. When analyzing the resection type, the CD grade-based complication rate (p = 0.013) and surgical site infection (SSI, p = 0.005) were significantly higher and the postoperative hospitalization was significantly longer (p = 0.028) in the bowl-shaped resection (BSR) group than in the edge- (ER) and dome-shaped resection (DSR) groups. The tumor size (p = 0.011) and IWATE criteria score (p = 0.006) were independent risk factors for intraoperative blood transfusion in the multivariate analysis. The tumor depth (p = 0.011) and BSR (p = 0.002) were independent risk factors for complications of CD grade 2 or higher in the multivariate analysis. BSR was an independent risk factor for SSI in the multivariate analysis (p = 0.017). Conclusions Resection type could predict the rate of postoperative complications, while the IWATE criteria could predict the intraoperative surgical difficulty.
- 13 July 2022
- Published by Springer Nature in Surgical Endoscopy
- Vol. 36 (12) , 9054-9063
Resection type is a predictor of postoperative complications in laparoscopic partial liver resection
Background Partial laparoscopic liver resection (LLR) is a procedure that can have varying levels of surgical difficulty depending on the tumor status and procedure. Therefore, we aimed to evaluate the surgical outcomes of partial LLR using a new resection classification system. Methods From January 2009 to May 2021, 156 patients underwent LLR; of them, 87 patients who underwent pure partial LLR were included in this study. They were classified according to the IWATE criteria as the low (n = 56) and intermediate (n = 31) difficulty groups and reclassified according to the resection type as the edge (ER, n = 45), bowl-shaped (BSR, n = 27), and dome-shaped resection (DSR, n = 15) groups. The following surgical outcomes were comparatively analyzed among the groups: intraoperative blood loss, the operation time, and complication rates. Preoperative risk factors for intraoperative blood transfusion and complications were evaluated. Results In the IWATE criteria-based analysis, the intermediate-difficulty group had significantly higher intraoperative blood loss (p = 0.005), operation time (p = 0.005), and Clavien–Dindo (CD) grade-based complication rates (CD grade 2 or higher, p = 0.03) than the low-difficulty group. When analyzing the resection type, the CD grade-based complication rate (p = 0.013) and surgical site infection (SSI, p = 0.005) were significantly higher and the postoperative hospitalization was significantly longer (p = 0.028) in the bowl-shaped resection (BSR) group than in the edge- (ER) and dome-shaped resection (DSR) groups. The tumor size (p = 0.011) and IWATE criteria score (p = 0.006) were independent risk factors for intraoperative blood transfusion in the multivariate analysis. The tumor depth (p = 0.011) and BSR (p = 0.002) were independent risk factors for complications of CD grade 2 or higher in the multivariate analysis. BSR was an independent risk factor for SSI in the multivariate analysis (p = 0.017). Conclusions Resection type could predict the rate of postoperative complications, while the IWATE criteria could predict the intraoperative surgical difficulty.
- Open Access
- 18 October 2021
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 9 (10) , e3877
A Three-dimensionally Printed Acrylonitrile Butadiene Styrene Model for the Reduction of Nasomaxillary Fracture
Summary: The successful reduction of a nasomaxillary fracture was performed using a three-dimensional printed model. A 16-year-old boy was struck in the left orbit by a baseball; subsequently, he was diagnosed with the nasal bone fracture at a hospital, and was referred to the authors’ department. A left nasomaxillary fracture and nasal bone fracture were diagnosed by computed tomography. Standard triangulated language data for the mirror image of the frontal process of the right maxilla were obtained from digital imaging and communications in medicine data for preparing a three-dimensional printed acrylonitrile butadiene styrene model. On postinjury day 13, the frontal process fracture was reduced via transconjunctival and intraoral approaches. After the reduction of the fracture, an absorbable plate fitting to the shape of three-dimensional printed acrylonitrile butadiene styrene model was molded, and the maxillary frontal process and infraorbital rim were reduced and fixed with an absorbable plate and screws. Postoperative computed tomography demonstrated a favorable reduction. The intraoperative use of the 3D printed acrylonitrile butadiene styrene model was helpful in the nasomaxillary fracture reduction and fixation.
- 18 October 2021
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 9 (10) , e3877
Open AccessA Three-dimensionally Printed Acrylonitrile Butadiene Styrene Model for the Reduction of Nasomaxillary Fracture
Summary: The successful reduction of a nasomaxillary fracture was performed using a three-dimensional printed model. A 16-year-old boy was struck in the left orbit by a baseball; subsequently, he was diagnosed with the nasal bone fracture at a hospital, and was referred to the authors’ department. A left nasomaxillary fracture and nasal bone fracture were diagnosed by computed tomography. Standard triangulated language data for the mirror image of the frontal process of the right maxilla were obtained from digital imaging and communications in medicine data for preparing a three-dimensional printed acrylonitrile butadiene styrene model. On postinjury day 13, the frontal process fracture was reduced via transconjunctival and intraoral approaches. After the reduction of the fracture, an absorbable plate fitting to the shape of three-dimensional printed acrylonitrile butadiene styrene model was molded, and the maxillary frontal process and infraorbital rim were reduced and fixed with an absorbable plate and screws. Postoperative computed tomography demonstrated a favorable reduction. The intraoperative use of the 3D printed acrylonitrile butadiene styrene model was helpful in the nasomaxillary fracture reduction and fixation.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 3-090
Inhibition of LAT1 activates GCN2-ATF4 survival pathway in Breast cancer cells.
LAT1 overexpressed in many cancer cells is an attractive therapeutic target because it provides cancer cells with essential amino acids required for proliferation. JPH203, a specific competitive inhibitor for LAT1, has been reported to suppress proliferation of cancer cells. Recently, we found that anti-tumor effects of JPH203 between MDA-MB-231 cells, a model of highly malignant breast cancer cells (=TNBC) and T-47D cells(=non-TNBC) were different. To investigate the difference in JPH203 sensitivity, we analyzed global gene expression change in JPH203-responsive T-47D cells in the presence or absence of JPH203. Among them, we focused on ATF4, a master transcription factor for stress response, which activates anti-apoptotic pathway. Knockdown of ATF4 in MDA-MB-231 cells, enhanced JPH203 induced cell death. Furthermore, some reports showed that ATF4 elicite CTH, the biosynthetic enzyme for cysteine, which protects TNBC from nutrient stress. Knockdown of CTH in MDA-MB-231 cells, also enhanced growth inhibition by JPH203 treatment. These results suggest that nutrient stress caused by JPH203-treatment activated anti-apoptotic signaling via ATF4 in MDA-MB-231 cells and that CTH inhibition could be a novel way of breaking resistance to anti-LAT1 therapy in MDA-MB-231 cells.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 3-090
Open AccessInhibition of LAT1 activates GCN2-ATF4 survival pathway in Breast cancer cells.
LAT1 overexpressed in many cancer cells is an attractive therapeutic target because it provides cancer cells with essential amino acids required for proliferation. JPH203, a specific competitive inhibitor for LAT1, has been reported to suppress proliferation of cancer cells. Recently, we found that anti-tumor effects of JPH203 between MDA-MB-231 cells, a model of highly malignant breast cancer cells (=TNBC) and T-47D cells(=non-TNBC) were different. To investigate the difference in JPH203 sensitivity, we analyzed global gene expression change in JPH203-responsive T-47D cells in the presence or absence of JPH203. Among them, we focused on ATF4, a master transcription factor for stress response, which activates anti-apoptotic pathway. Knockdown of ATF4 in MDA-MB-231 cells, enhanced JPH203 induced cell death. Furthermore, some reports showed that ATF4 elicite CTH, the biosynthetic enzyme for cysteine, which protects TNBC from nutrient stress. Knockdown of CTH in MDA-MB-231 cells, also enhanced growth inhibition by JPH203 treatment. These results suggest that nutrient stress caused by JPH203-treatment activated anti-apoptotic signaling via ATF4 in MDA-MB-231 cells and that CTH inhibition could be a novel way of breaking resistance to anti-LAT1 therapy in MDA-MB-231 cells.
- Open Access
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-022
Functional analysis of mutant SLCO2A1 transporter responsible for human intractable small intestinal ulcer
【Background】Chronic nonspecific multiple ulcers of the small intestine (CNSU) is an intractable disease presenting with chronic anemia and hypoalbuminemia. Recently, mutations in slco2a1 gene coding prostaglandin (PG) transporter protein have been shown to be causative for CNSU and a new disease entity "chronic enteropathy associated with SLCO2A1(CEAS)" has been proposed. However, detailed mechanisms of how mutant SLCO2A1 protein involved in the development of CEAS has not been fully elucidated. In this study, we investigated transporter function of mutant SLCO2A1 proteins identified in the patients with CEAS.【Method】Synthesized cRNAs for wild type or 5 known mutants were injected into Xenopus oocytes. After 2 days incubation, these oocytes were treated with various concentrations of 3H-PGE2 for 30 min and amount of transport was measured by counting radioactivity of cell lysates.【Results and discussion】Consistent with previous reports, wild type SLCO2A1-expressed oocytes took up PGE2. A mutant with 97GC showed comparable PGE2 transport capability to wild type, while 3 mutants, 1647GT, 830dupT, and 830delT exhibited very little PGE2 transport activity. Another mutant, 1372GT, transported some PGE2 with markedly suppressed Vmax with little change in Km value. Most mutations in SLCO2A1 gene present in CEAS patients affected Vmax suggesting these mutations inhibited cell surface expression of the transporter rather than changing the affinity to the substrate. Since this assay employed a heterologous overexpression system, transport activity of 97GC mutant should be evaluated in a mammalian expression system.
- 1 January 2020
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 93, 2-022
Open AccessFunctional analysis of mutant SLCO2A1 transporter responsible for human intractable small intestinal ulcer
【Background】Chronic nonspecific multiple ulcers of the small intestine (CNSU) is an intractable disease presenting with chronic anemia and hypoalbuminemia. Recently, mutations in slco2a1 gene coding prostaglandin (PG) transporter protein have been shown to be causative for CNSU and a new disease entity "chronic enteropathy associated with SLCO2A1(CEAS)" has been proposed. However, detailed mechanisms of how mutant SLCO2A1 protein involved in the development of CEAS has not been fully elucidated. In this study, we investigated transporter function of mutant SLCO2A1 proteins identified in the patients with CEAS.【Method】Synthesized cRNAs for wild type or 5 known mutants were injected into Xenopus oocytes. After 2 days incubation, these oocytes were treated with various concentrations of 3H-PGE2 for 30 min and amount of transport was measured by counting radioactivity of cell lysates.【Results and discussion】Consistent with previous reports, wild type SLCO2A1-expressed oocytes took up PGE2. A mutant with 97GC showed comparable PGE2 transport capability to wild type, while 3 mutants, 1647GT, 830dupT, and 830delT exhibited very little PGE2 transport activity. Another mutant, 1372GT, transported some PGE2 with markedly suppressed Vmax with little change in Km value. Most mutations in SLCO2A1 gene present in CEAS patients affected Vmax suggesting these mutations inhibited cell surface expression of the transporter rather than changing the affinity to the substrate. Since this assay employed a heterologous overexpression system, transport activity of 97GC mutant should be evaluated in a mammalian expression system.
- Open Access
- 1 October 2019
- Published by The Nihon University Medical Association in Journal of Nihon University Medical Association
- Vol. 78 (5) , 301-304
A Case of Traumatic Diaphragmatic Hernia due to a Stab Wound
本邦では外傷性横隔膜ヘルニアは鈍的外傷に起因することが多く,刺創かつ遅発性に発症するものは稀である.症例は 26 歳女性.4 か月前に右背部を刃物で刺された.外傷性気胸に対し,保存的に加療された.2か月後,胸部 X 線写真で右横隔膜上に経時的に増大する腫瘤影を認めた.胸部 CT にて右胸腔内に肝臓の脱出を認め,遅発性横隔膜ヘルニアの診断で手術を施行した.
- 1 October 2019
- Published by The Nihon University Medical Association in Journal of Nihon University Medical Association
- Vol. 78 (5) , 301-304
Open AccessA Case of Traumatic Diaphragmatic Hernia due to a Stab Wound
本邦では外傷性横隔膜ヘルニアは鈍的外傷に起因することが多く,刺創かつ遅発性に発症するものは稀である.症例は 26 歳女性.4 か月前に右背部を刃物で刺された.外傷性気胸に対し,保存的に加療された.2か月後,胸部 X 線写真で右横隔膜上に経時的に増大する腫瘤影を認めた.胸部 CT にて右胸腔内に肝臓の脱出を認め,遅発性横隔膜ヘルニアの診断で手術を施行した.
- 10 September 2019
- Published by Wiley in World Journal of Surgery
- Vol. 43 (12) , 3259-3266
Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer
Good prognosis following surgery for metachronous lung cancer has been reported. However, prognostic factors have not been fully investigated. The purpose of this study was to identify the preoperative predictor of survival in metachronous lung cancer.
- 10 September 2019
- Published by Wiley in World Journal of Surgery
- Vol. 43 (12) , 3259-3266
Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer
Good prognosis following surgery for metachronous lung cancer has been reported. However, prognostic factors have not been fully investigated. The purpose of this study was to identify the preoperative predictor of survival in metachronous lung cancer.
- Open Access
- 1 September 2019
- Published by International College of Surgeons in International Surgery
- Vol. 104 (9-10) , 412-422
Dual Effects of Large Spleen Volume After Splenectomy for the Patients With Chronic Liver Disease
Background: After splenectomy in patients with chronic liver disease, a large spleen was reported to be not only a risk factor of portal/splenic vein thrombosis (PSVT), but also a prediction for favorable improvement of liver function. This study aimed to evaluate the risk of PSVT and the improvement of liver function after splenectomy, with special attention to spleen volume (SV). Methods: This studied included 50 patients who underwent splenectomy with diagnosed chronic liver disease between January 2005 and December 2017. After evaluation of risk factors for PSVT the cut-off value of SV for predicting PSVT was determined. According to the cut-off value of SV, 50 patients were divided into 2 groups: small-volume group (SVG) and large-volume group (LVG). Postoperative liver functions were compared between the 2 groups. Results: Twenty-eight patients developed PSVT. Larger SV was the most significant independent risk factor for PSVT. The cut-off value of SV was 520 mL. Preoperatively, LVG had significantly higher total bilirubin, and MELD (model for end-stage liver disease) score, and had significantly higher rates of pancytopenia than SVG. Postoperatively, compared to SVG, platelet count, choline esterase, and total cholesterol in LVG were significantly increased. Conclusion: After splenectomy in the patients with chronic liver disease, large SV is an independent risk factor for PSVT, with a clear benefit in improving liver function, if PSVT is properly diagnosed and managed.
- 1 September 2019
- Published by International College of Surgeons in International Surgery
- Vol. 104 (9-10) , 412-422
Open AccessDual Effects of Large Spleen Volume After Splenectomy for the Patients With Chronic Liver Disease
Background: After splenectomy in patients with chronic liver disease, a large spleen was reported to be not only a risk factor of portal/splenic vein thrombosis (PSVT), but also a prediction for favorable improvement of liver function. This study aimed to evaluate the risk of PSVT and the improvement of liver function after splenectomy, with special attention to spleen volume (SV). Methods: This studied included 50 patients who underwent splenectomy with diagnosed chronic liver disease between January 2005 and December 2017. After evaluation of risk factors for PSVT the cut-off value of SV for predicting PSVT was determined. According to the cut-off value of SV, 50 patients were divided into 2 groups: small-volume group (SVG) and large-volume group (LVG). Postoperative liver functions were compared between the 2 groups. Results: Twenty-eight patients developed PSVT. Larger SV was the most significant independent risk factor for PSVT. The cut-off value of SV was 520 mL. Preoperatively, LVG had significantly higher total bilirubin, and MELD (model for end-stage liver disease) score, and had significantly higher rates of pancytopenia than SVG. Postoperatively, compared to SVG, platelet count, choline esterase, and total cholesterol in LVG were significantly increased. Conclusion: After splenectomy in the patients with chronic liver disease, large SV is an independent risk factor for PSVT, with a clear benefit in improving liver function, if PSVT is properly diagnosed and managed.
- Open Access
- 4 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-12
Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes
Background. Circulating apolipoprotein-AII (apoAII-) ATQ/AT is a potential useful biomarker for early stage pancreatic ductal adenocarcinoma (PDAC), but its clinical significance in PDAC patients remains uncertain. The aim of the current study was to assess the usefulness of apoAII-ATQ/AT as a surrogate for the effect of chemoradiotherapy (CRT) and its association with pancreatic exocrine disorder, paying attention to morphological changes of the pancreas. Methods. In the 264 PDAC patients who were enrolled in our CRT protocol, the following parameters were measured at specified time points before and after CRT: serum levels of albumin, total cholesterol, and amylase as indices of pancreatic exocrine function, serum levels of CA19-9, and the pancreatic morphology including tumor size (TS), main pancreatic duct diameter (MPDD), and pancreatic parenchymal volume excluding tumor volume (PPV) by using computed tomography (CT) images. Plasma apoAII-ATQ/AT levels were simultaneously measured with enzyme-linked immunosorbent assay in 4 healthy volunteers and the 44 PDAC patients before and after CRT. Plasma apoAII-ATQ/AT levels after CRT were analyzed according to small/large-MPDD and small/large-PPV groups based on their median values after CRT. Plasma samples after CRT were measured after incubation with human pancreatic juice (PJ) to examine the relevance between apoAII isoforms and circulating pancreatic enzymes. Results. The serum levels of albumin, amylase, CA19-9, TS, MPDD, and PPV after CRT were significantly lower than those before CRT (median, before vs. after: 3.9 g/dl, 74 U/l, 180.2 U/ml, 58.1 mm, 4.0 mm, and 34.8 ml vs. 3.8, 59, 43.5, 55.6, 3.6, and 25.2). ApoAII-ATQ/AT levels (median, μg/ml) of PDAC patients before CRT were significantly lower than those in healthy volunteers: 32.9 vs. 61.2, and unexpectedly those after CRT significantly decreased: 14.7. The reduction rate of apoAII-ATQ/AT was not correlated with those of CA19-9 and TS, indicating that apoAII-ATQ/AT is not a tumor-specific marker. On the other hand, the patient group with large MPDD and small PV exhibited higher apoAII-ATQ levels than those with small MPDD and large PPV. The incubation of plasma samples after CRT with PJ did not alter apoAII-ATQ/AT and apoAII-AT levels but significantly decreased apoAII-ATQ levels, suggesting that circulating pancreatic enzymes markedly influenced apoAII-ATQ levels. Conclusions. ApoAII-ATQ/AT levels are not useful for evaluation of clinical effect of CRT for PDAC, but apoAII isoforms are very useful to assess pancreatic exocrine disorder because pancreatic atrophy and insufficient secretion of circulating pancreatic enzymes are considered likely to influence apoAII-ATQ levels.
- 4 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-12
Open AccessClinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes
Background. Circulating apolipoprotein-AII (apoAII-) ATQ/AT is a potential useful biomarker for early stage pancreatic ductal adenocarcinoma (PDAC), but its clinical significance in PDAC patients remains uncertain. The aim of the current study was to assess the usefulness of apoAII-ATQ/AT as a surrogate for the effect of chemoradiotherapy (CRT) and its association with pancreatic exocrine disorder, paying attention to morphological changes of the pancreas. Methods. In the 264 PDAC patients who were enrolled in our CRT protocol, the following parameters were measured at specified time points before and after CRT: serum levels of albumin, total cholesterol, and amylase as indices of pancreatic exocrine function, serum levels of CA19-9, and the pancreatic morphology including tumor size (TS), main pancreatic duct diameter (MPDD), and pancreatic parenchymal volume excluding tumor volume (PPV) by using computed tomography (CT) images. Plasma apoAII-ATQ/AT levels were simultaneously measured with enzyme-linked immunosorbent assay in 4 healthy volunteers and the 44 PDAC patients before and after CRT. Plasma apoAII-ATQ/AT levels after CRT were analyzed according to small/large-MPDD and small/large-PPV groups based on their median values after CRT. Plasma samples after CRT were measured after incubation with human pancreatic juice (PJ) to examine the relevance between apoAII isoforms and circulating pancreatic enzymes. Results. The serum levels of albumin, amylase, CA19-9, TS, MPDD, and PPV after CRT were significantly lower than those before CRT (median, before vs. after: 3.9 g/dl, 74 U/l, 180.2 U/ml, 58.1 mm, 4.0 mm, and 34.8 ml vs. 3.8, 59, 43.5, 55.6, 3.6, and 25.2). ApoAII-ATQ/AT levels (median, μg/ml) of PDAC patients before CRT were significantly lower than those in healthy volunteers: 32.9 vs. 61.2, and unexpectedly those after CRT significantly decreased: 14.7. The reduction rate of apoAII-ATQ/AT was not correlated with those of CA19-9 and TS, indicating that apoAII-ATQ/AT is not a tumor-specific marker. On the other hand, the patient group with large MPDD and small PV exhibited higher apoAII-ATQ levels than those with small MPDD and large PPV. The incubation of plasma samples after CRT with PJ did not alter apoAII-ATQ/AT and apoAII-AT levels but significantly decreased apoAII-ATQ levels, suggesting that circulating pancreatic enzymes markedly influenced apoAII-ATQ levels. Conclusions. ApoAII-ATQ/AT levels are not useful for evaluation of clinical effect of CRT for PDAC, but apoAII isoforms are very useful to assess pancreatic exocrine disorder because pancreatic atrophy and insufficient secretion of circulating pancreatic enzymes are considered likely to influence apoAII-ATQ levels.
- Open Access
- 4 December 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 619
A case of hepatic anisakiasis caused by Pseudoterranova decipiens mimicking metastatic liver cancer
Anisakid nematodes (Anisakis spp. or Pseudoterranova spp.) usually infect gastric or intestinal walls, while they rarely infect in extra-gastrointestinal sites of human body. Generally, Anisakis spp. larvae are highly infected in fish intermediate hosts, whereas Pseudoterranova spp. larvae are very rarely infected. To the best of our knowledge, there have been no reports which have documented cases of hepatic anisakiasis caused by Pseudoterranova spp. This report describes the first documented case of hepatic anisakiasis due to infection with Pseudoterranova decipiens and clinical features of the hepatic anisakiasis through literature review. The case was a 28-year-old man with prior history of malignancy who was found to have a hepatic mass mimicking metastatic liver tumor. A new low density area of 20 mm in diameter in liver segment 7 was found on follow-up CT. With suspicious diagnosis of metastatic liver cancer, laparoscopic partial hepatectomy was performed. A pathological examination revealed no evidence of malignancy, but showed necrotic granuloma with eosinophil infiltration and the presence of a larva with Y-shaped lateral cords, which are specific to anisakid larvae. The type of larva was identified as Pseudoterranova decipiens sensu lato using PCR of DNA purified from a fixed granuloma embedded in paraffin. The present report is the first to discuss the case of a patient with hepatic anisakiasis caused by Pseudoterranova decipiens. Hepatic anisakiasis is a potential differential diagnosis for hepatic tumors and genetic identification with the PCR method was reliable for obtaining final diagnosis even when the larvae body in the resected specimen collapses with time.
- 4 December 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 619
Open AccessA case of hepatic anisakiasis caused by Pseudoterranova decipiens mimicking metastatic liver cancer
Anisakid nematodes (Anisakis spp. or Pseudoterranova spp.) usually infect gastric or intestinal walls, while they rarely infect in extra-gastrointestinal sites of human body. Generally, Anisakis spp. larvae are highly infected in fish intermediate hosts, whereas Pseudoterranova spp. larvae are very rarely infected. To the best of our knowledge, there have been no reports which have documented cases of hepatic anisakiasis caused by Pseudoterranova spp. This report describes the first documented case of hepatic anisakiasis due to infection with Pseudoterranova decipiens and clinical features of the hepatic anisakiasis through literature review. The case was a 28-year-old man with prior history of malignancy who was found to have a hepatic mass mimicking metastatic liver tumor. A new low density area of 20 mm in diameter in liver segment 7 was found on follow-up CT. With suspicious diagnosis of metastatic liver cancer, laparoscopic partial hepatectomy was performed. A pathological examination revealed no evidence of malignancy, but showed necrotic granuloma with eosinophil infiltration and the presence of a larva with Y-shaped lateral cords, which are specific to anisakid larvae. The type of larva was identified as Pseudoterranova decipiens sensu lato using PCR of DNA purified from a fixed granuloma embedded in paraffin. The present report is the first to discuss the case of a patient with hepatic anisakiasis caused by Pseudoterranova decipiens. Hepatic anisakiasis is a potential differential diagnosis for hepatic tumors and genetic identification with the PCR method was reliable for obtaining final diagnosis even when the larvae body in the resected specimen collapses with time.
- Open Access
- 18 November 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-8
The Critical Role of Biliary Candidiasis in Development of Surgical Site Infections after Pancreatoduodenectomy: Results of Prospective Study Using a Selective Culture Medium for Candida Species
In accordance with previous reports, the incidence of biliary candidiasis (BC) after pancreaticoduodenectomy (PD) was reported to be 0 to 5%, and the clinical significance of BC still has been elusive. In this study, we prospectively evaluated the precise incidence of BC after PD using the CHROMagar Candida plate in an attempt to elucidate whether BC has a significant impact on the clinical outcomes after PD.Patients and Method. From November 2014 to March 2016, the consecutive 51 patients who underwent PD were enrolled for this study. The bile juice was prospectively collected through the biliary stent tube on postoperative days (POD) 3, 7, and 14 and directly incubated onto the CHROMagar Candida plate for the cultivation of various Candida species. In the presence or absence of BC, we compared the incidence of SSIs.Results. The incidence of postoperative BC was 15% on POD 3, 24% on POD 7, and 39% on POD 14, respectively. Taken together, 22 patients out of 51 (43.1%) developed BC after PD. Moreover, the incidence of SSIs was significantly higher in patients with BC than in those without it (71% versus 7%, p=0.005). BC was selected as the only significant risk factor of SSIs after PD among the various risk factors. Even though a cause of BC is unknown, high level of alkaline phosphatase (cut-off line >300 IU/L) was selected as the only preoperative risk factor of the development of BC.Conclusion. We elucidated new evidence in which BC could be the independent cause of SSIs after PD and should not be recognized as just contamination artifacts. Preoperative assessment for identifying carriers of Candida species might be essential for reducing the incidence of SSIs after PD.
- 18 November 2018
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-8
Open AccessThe Critical Role of Biliary Candidiasis in Development of Surgical Site Infections after Pancreatoduodenectomy: Results of Prospective Study Using a Selective Culture Medium for Candida Species
In accordance with previous reports, the incidence of biliary candidiasis (BC) after pancreaticoduodenectomy (PD) was reported to be 0 to 5%, and the clinical significance of BC still has been elusive. In this study, we prospectively evaluated the precise incidence of BC after PD using the CHROMagar Candida plate in an attempt to elucidate whether BC has a significant impact on the clinical outcomes after PD.Patients and Method. From November 2014 to March 2016, the consecutive 51 patients who underwent PD were enrolled for this study. The bile juice was prospectively collected through the biliary stent tube on postoperative days (POD) 3, 7, and 14 and directly incubated onto the CHROMagar Candida plate for the cultivation of various Candida species. In the presence or absence of BC, we compared the incidence of SSIs.Results. The incidence of postoperative BC was 15% on POD 3, 24% on POD 7, and 39% on POD 14, respectively. Taken together, 22 patients out of 51 (43.1%) developed BC after PD. Moreover, the incidence of SSIs was significantly higher in patients with BC than in those without it (71% versus 7%, p=0.005). BC was selected as the only significant risk factor of SSIs after PD among the various risk factors. Even though a cause of BC is unknown, high level of alkaline phosphatase (cut-off line >300 IU/L) was selected as the only preoperative risk factor of the development of BC.Conclusion. We elucidated new evidence in which BC could be the independent cause of SSIs after PD and should not be recognized as just contamination artifacts. Preoperative assessment for identifying carriers of Candida species might be essential for reducing the incidence of SSIs after PD.